Market Cap

Hansa Biopharma AB Market Capitalization:

kr1.37 Billion

SEK as of Jan. 1, 2024

US$136.5 Million

business Hansa Biopharma AB Company Profile

Hansa Biopharma AB Main Stock Listing

OMX: HNSA

Market Capitalization History of Hansa Biopharma AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Hansa Biopharma AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr1.37 B -63.43%
Jan. 1, 2023 kr3.76 B -6.17%
Jan. 1, 2022 kr4.00 B -58.97%
Jan. 1, 2021 kr9.76 B 150.52%
Jan. 1, 2020 kr3.90 B -69.99%
Jan. 1, 2019 kr12.98 B -9.52%
Jan. 1, 2018 kr14.35 B 131.09%
Jan. 1, 2017 kr6.21 B 400.00%
Jan. 1, 2016 kr1.24 B -49.77%
Jan. 1, 2015 kr2.47 B 244.06%
Jan. 1, 2014 kr718.4 M 216.26%
Jan. 1, 2013 kr227.2 M -4.15%
Jan. 1, 2012 kr237.0 M -2.09%
Jan. 1, 2011 kr242.1 M -49.13%
Jan. 1, 2010 kr475.9 M 159.59%
Jan. 1, 2009 kr183.3 M -47.88%
Jan. 1, 2008 kr351.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Hansa Biopharma AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Hansa Biopharma AB has the following listings and related stock indices.


Stock: OMX: HNSA

Stock: FSX: 24H

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.